The Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes

To study effect of nanomedicine on lower extremity deep vein thrombosis (LEDVT) and its correlation with susceptibility genes (SGs), preliminary nanoparticle LSA was constructed using lauric acid and stearic acid, and CTAB-HAuCL4-TEOS (CHT) was obtained using cetyltrimethyl ammonium bromide (CTAB),...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Rong Chang, Chunsheng Wang, Xiangqi Kong, Wenhui Li, Jinchun Wu
Formato:	article
Lenguaje:	EN
Publicado:	Taylor & Francis Group 2021
Materias:	lower extremity deep vein thrombosis susceptibility gene cytotoxicity test frequency of allele nanomedicine Biotechnology TP248.13-248.65
Acceso en línea:	https://doaj.org/article/f4597470cf2b467097b5b14dcc40be23
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f4597470cf2b467097b5b14dcc40be23
record_format	dspace
spelling	oai:doaj.org-article:f4597470cf2b467097b5b14dcc40be232021-11-26T11:19:49ZThe Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes2165-59792165-598710.1080/21655979.2021.2003926https://doaj.org/article/f4597470cf2b467097b5b14dcc40be232021-11-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.2003926https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987To study effect of nanomedicine on lower extremity deep vein thrombosis (LEDVT) and its correlation with susceptibility genes (SGs), preliminary nanoparticle LSA was constructed using lauric acid and stearic acid, and CTAB-HAuCL4-TEOS (CHT) was obtained using cetyltrimethyl ammonium bromide (CTAB), chloroauric acid (HAuCL4), and tetraethoxysilane (TEOS) to prepare UK-LSA-CHT by combining with urokinase (UK). 20 rabbits were grouped into UK-LSA-CHT, LSA, UK, and D0 group. Human umbilical vein endothelial cells (HUVEC) were selected for cytotoxicity test. The plasma endothelin (ET-1), interleukin 6 (IL-6), and nuclear factor κβ (NF-κβ) of the rabbits were detected with double antibody sandwich method. Expression of platelet activating factor (PAF) was detected by immumohistochemical staining. Genotype distribution was detected with the second-generation sequencing technology (SGST). The results showed that expressions of ET-1, IL-6, and NF-κβ) in UK-LSA-CHT group were lower than those in the LSA group and the UK group after 12 hours (P < 0.05). Frequency of allele G and T, and GT and TT genotype ratio of SG NOS3 rs1799983 in UK -LSA-CHT group were less than those in LSA and UK group (P < 0.05). UK-LSA-CHT group had observably lower value in PAF positive expression than LSA and UK groups (P < 0.05). In short, UK-LSA-CHT had good biocompatibility and safety and good therapeutic effect on LEDVT. N0S3 rs1799983 alleles G and T may be the key risk factors for the occurrence and development of LEDVT.Rong ChangChunsheng WangXiangqi KongWenhui LiJinchun WuTaylor & Francis Grouparticlelower extremity deep vein thrombosissusceptibility genecytotoxicity testfrequency of allelenanomedicineBiotechnologyTP248.13-248.65ENBioengineered, Vol 0, Iss 0 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	lower extremity deep vein thrombosis susceptibility gene cytotoxicity test frequency of allele nanomedicine Biotechnology TP248.13-248.65
spellingShingle	lower extremity deep vein thrombosis susceptibility gene cytotoxicity test frequency of allele nanomedicine Biotechnology TP248.13-248.65 Rong Chang Chunsheng Wang Xiangqi Kong Wenhui Li Jinchun Wu The Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes
description	To study effect of nanomedicine on lower extremity deep vein thrombosis (LEDVT) and its correlation with susceptibility genes (SGs), preliminary nanoparticle LSA was constructed using lauric acid and stearic acid, and CTAB-HAuCL4-TEOS (CHT) was obtained using cetyltrimethyl ammonium bromide (CTAB), chloroauric acid (HAuCL4), and tetraethoxysilane (TEOS) to prepare UK-LSA-CHT by combining with urokinase (UK). 20 rabbits were grouped into UK-LSA-CHT, LSA, UK, and D0 group. Human umbilical vein endothelial cells (HUVEC) were selected for cytotoxicity test. The plasma endothelin (ET-1), interleukin 6 (IL-6), and nuclear factor κβ (NF-κβ) of the rabbits were detected with double antibody sandwich method. Expression of platelet activating factor (PAF) was detected by immumohistochemical staining. Genotype distribution was detected with the second-generation sequencing technology (SGST). The results showed that expressions of ET-1, IL-6, and NF-κβ) in UK-LSA-CHT group were lower than those in the LSA group and the UK group after 12 hours (P < 0.05). Frequency of allele G and T, and GT and TT genotype ratio of SG NOS3 rs1799983 in UK -LSA-CHT group were less than those in LSA and UK group (P < 0.05). UK-LSA-CHT group had observably lower value in PAF positive expression than LSA and UK groups (P < 0.05). In short, UK-LSA-CHT had good biocompatibility and safety and good therapeutic effect on LEDVT. N0S3 rs1799983 alleles G and T may be the key risk factors for the occurrence and development of LEDVT.
format	article
author	Rong Chang Chunsheng Wang Xiangqi Kong Wenhui Li Jinchun Wu
author_facet	Rong Chang Chunsheng Wang Xiangqi Kong Wenhui Li Jinchun Wu
author_sort	Rong Chang
title	The Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes
title_short	The Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes
title_full	The Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes
title_fullStr	The Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes
title_full_unstemmed	The Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes
title_sort	role of second generation sequencing technology and nanomedicine in the monitoring and treatment of lower extremity deep vein thrombosis susceptibility genes
publisher	Taylor & Francis Group
publishDate	2021
url	https://doaj.org/article/f4597470cf2b467097b5b14dcc40be23
work_keys_str_mv	AT rongchang theroleofsecondgenerationsequencingtechnologyandnanomedicineinthemonitoringandtreatmentoflowerextremitydeepveinthrombosissusceptibilitygenes AT chunshengwang theroleofsecondgenerationsequencingtechnologyandnanomedicineinthemonitoringandtreatmentoflowerextremitydeepveinthrombosissusceptibilitygenes AT xiangqikong theroleofsecondgenerationsequencingtechnologyandnanomedicineinthemonitoringandtreatmentoflowerextremitydeepveinthrombosissusceptibilitygenes AT wenhuili theroleofsecondgenerationsequencingtechnologyandnanomedicineinthemonitoringandtreatmentoflowerextremitydeepveinthrombosissusceptibilitygenes AT jinchunwu theroleofsecondgenerationsequencingtechnologyandnanomedicineinthemonitoringandtreatmentoflowerextremitydeepveinthrombosissusceptibilitygenes AT rongchang roleofsecondgenerationsequencingtechnologyandnanomedicineinthemonitoringandtreatmentoflowerextremitydeepveinthrombosissusceptibilitygenes AT chunshengwang roleofsecondgenerationsequencingtechnologyandnanomedicineinthemonitoringandtreatmentoflowerextremitydeepveinthrombosissusceptibilitygenes AT xiangqikong roleofsecondgenerationsequencingtechnologyandnanomedicineinthemonitoringandtreatmentoflowerextremitydeepveinthrombosissusceptibilitygenes AT wenhuili roleofsecondgenerationsequencingtechnologyandnanomedicineinthemonitoringandtreatmentoflowerextremitydeepveinthrombosissusceptibilitygenes AT jinchunwu roleofsecondgenerationsequencingtechnologyandnanomedicineinthemonitoringandtreatmentoflowerextremitydeepveinthrombosissusceptibilitygenes
_version_	1718409508312580096

The Role of Second Generation Sequencing Technology and Nanomedicine in the Monitoring and Treatment of Lower Extremity Deep Vein Thrombosis Susceptibility Genes

Ejemplares similares